Infectious Diseases and Antimicrobial Therapy Review

0.0(0)
Studied by 0 people
call kaiCall Kai
Locked
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/60

flashcard set

Earn XP

Description and Tags

Flashcards covering Community-Acquired Pneumonia (CAP), UTIs, SSTIs, C.diff, HIV management, and general antimicrobial principles based on lecture notes.

Last updated 9:08 PM on 7/28/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

61 Terms

1
New cards

Community-Acquired Pneumonia (CAP) Diagnosis Confirmation

Diagnosis is confirmed by a Chest X-ray.

2
New cards

CAP common pathogen

Strep. Pneumonaie

3
New cards

First-line Treatment for Healthy Outpatient CAP

Amoxicillin or Doxycycline.

4
New cards

First-line Treatment for CAP Outpatient with Comorbidities

Augmentin + azithromycin or doxycycline.

5
New cards

First-line Treatment for Inpatient CAP

Ceftriaxone + azithromycin.

6
New cards

CAP Treatment Duration

55 days.

7
New cards

Common Pathogen in UTI

E.coli.

8
New cards

Cystitis Symptoms

Dysuria, Frequency, and Urgency.

9
New cards

Pyelnephritis Identification

Fever, Flank pain, and CVA tenderness.

10
New cards

UTI Lab

Urine culture

11
New cards

Uncomplicated Cystitis Treatment Options

  • Macrobid x 55 days

  • Bactrim x 33 days

  • Fosfomycin x 11 dose.

12
New cards

Pyelonephritis Tx

  • FQ

  • IV ceftriaxone

13
New cards

Nonpurulent SSTI Classification

Cellulitis and Erysipelas.

14
New cards

Purulent SSTI Classification

Abscess, Furuncle, and Carbuncle.

15
New cards

Nonpurulent SSTI Pathogens

Strep pyogenes and MSAA.

16
New cards

Purulent SSTI Pathogen

MRSA.

17
New cards

Cellulitis (Nonpurulent) First-line Treatment

Cephalexin or Cephazolin.

18
New cards

Purulent SSTI pathogen

  • MRSA

19
New cards

Purulent SSTI Treatment

  • Doxycycline

  • Clindamycin

20
New cards

Moderate purulent SSTI treatment

  • Bactrim

  • Doxy

  • Clindamycin

21
New cards

Severe purulent SSTI treatment

Vancomycin.

22
New cards

SSTI Treatment duration

5 days

23
New cards

C.diff Risk Factors

Antibiotics, hospitilzation, and PPI use.

24
New cards

Non-severe C.diff Criteria

WBC <15,000< 15,000 cells and SCr <1.5< 1.5.

25
New cards

Severe C.diff Criteria

WBC >15,000> 15,000 and SCr > ⅕> ⅕.

26
New cards

Fulminant C.diff Symptoms

HoTN or shock, Illeus, and Megacolon.

27
New cards

Non-severe C.diff First-line Treatment

  • Fidaxomicin BID x 1010 days

  • Vancomycin QID x 1010 days

  • Metronidazole TID x 1010 days.

28
New cards

Severe C.diff

  • Fidaxomicin BID

  • Vancomycin QID

29
New cards

Fulminant C.diff treatment

Vancomycin PO QID + metronidazole IV Q8H x 10-14 days

30
New cards

Recurrent C.diff Tx

  • Fidaxomicin PO BID x 10 days or taper/pulse x 20 days

  • Vancomycin PO QID x 10 days or taper/pulse x 2-8 weeks

31
New cards

PJP Prophylaxis in HIV

Indicated when CD4  < 200;

Treatment is Bactrim.

32
New cards

Toxoplasmosis Prophylaxis in HIV

Indicated when CD4  < 100

Treatment is Bactrim.

33
New cards

MAC Prophylaxis in HIV

Indicated when CD4  < 50

Treatment is Azithromycin.

34
New cards

HIV tx no hx of cabotegravir

  • Biktarvy

  • Dovato

  • DTG + tenofovir +FTC/3TC

35
New cards

HIV tx hx of cabotegravir

  • Symtuza

  • Darunavir/cobicstat

  • Darunavir/ritonavir

36
New cards

HIV PEP (Post-Exposure Prophylaxis) Protocol

  • Start within 7272 hours,

  • continue for 2828 days,

  • using a 33 drug regimen

    • Biktarvy.

37
New cards

Preferred option for HIV PrEP (Pre-Exposure Prophylaxis) in high-risk patients

Truvada (TDF/FTC)

38
New cards

Influenza Treatment Timing

Oseltamivir should be started within 4848 hours of symptoms for a

39
New cards

Oseltamivir treatment duration

55 days.

40
New cards

Live Vaccines List

MMR, Varicella, Liver zoster (for patients >50> 50 YO), and Intranasal flue.

41
New cards

Inactivated Vaccines List

Flue, PCV20/23 (for patients >50> 50), Covid, Hepatitis, Tdap, and RSV.

42
New cards

MRSA Coverage Agents

  • Vancomycin

  • Linzeloid

  • Bactrim

  • Daptomycin

  • Doxycycline

  • Clindamycin

  • Ceftaroline.

43
New cards

Pseudomonas Coverage Agents

  • Zosyn

  • cefepime

  • meropenem

  • aztreonam

  • Ciproflaxocin

  • Levofloxacin

  • Ceftazidine.

44
New cards

Atypical Pathogen Coverage

Azithromycin, Doxycycline, and FQs (-floxacin).

45
New cards

Anaerobe Coverage Agents

  • Metronidazole

  • Zosyn

  • Ampicillin-sulbactam

  • Carbapenems

  • Clindamycin.

46
New cards

Time Dependent

  • Beta Lactams

    • penicillins

    • cephalosporins

    • carbapenems

47
New cards

Concentration dependent

  • AGs

  • FGs

48
New cards

AUC/MIC

Vancomycin

49
New cards

Vancomycin Trough AUC/MIC Target

400600400-600.

50
New cards

Bactericidal Agents

  • Beta-lactams (Penicillins, Cephalosporins)

  • Carbapenems

  • Vancomycin

  • FQs

  • AGs

  • Metronidazole.

51
New cards

Bacteriostatic Agents

  • Macrolides (-mycins)

  • Tetracyclines (-cyclones)

  • Clindamyin

  • Sufnonamides

  • Linezolid.

52
New cards

Vancomycin Major Side Effects

Nephrotoxicity and Red man syndrome.

53
New cards

FQ Major Side Effects

Tendon rupture and QT prolong.

54
New cards

Bactrim Major Side Effects

Hyperkalemia, Rash, and BMS.

55
New cards

Macrobid Precautions

Avoid in poor renal function; may cause Pulmonary toxicity.

56
New cards

Metronidazole Specific Reaction

Disulfiram life rxn.

57
New cards

Tetracycline Side Effects

Photosensitivity and Tooth discoloration; avoid in pregnancy and young kids.

58
New cards

Clindamycin Major Side Effect

C.diff diarrhea.

59
New cards

Severe Nonpurulent SSTI treatment

Vancomycin + Zosyn

60
New cards

Complicated UTI treatment duration with FQs

7 days

61
New cards

Complicated UTI treatment duration

5 days